Profile
BWV NVO VRTX REGN SGEN MRNA
Company Name Blue Water Vaccines, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Moderna, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.41M $557.99B $102.34B $96.34B $43.15B $42.74B
Employees 0.01K 63.37K 5.40K 13.45K 3.26K 5.60K
CEO Dr. Neil J. Campbell MA, MBA Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Stephane Bancel
Ratings
BWV NVO VRTX REGN SGEN MRNA
Quant Rating Score 3 5 5 5 3 4
Quant Rating Neutral Strong Buy Strong Buy Strong Buy Neutral Buy
Trading
BWV NVO VRTX REGN SGEN MRNA
Last Close $0.1802 $126.88 $396.2 $892.48 $228.74 $111.62
High 52 $1.29 $199.54 $446.08 $993.35 $228.9 $137.75
Low 52 $0.18 $87.78 $323.57 $692.45 $187.64 $69.51
Price vs. 52 Week High -86.03 % -36.41 % -11.18 % -10.15 % -0.07 % -18.97 %
Price vs. 52 Week Low 0.11 % 44.54 % 22.45 % 28.89 % 21.9 % 60.58 %
Total Return
BWV NVO VRTX REGN SGEN MRNA
1 Month Return 0 % -1.18 % -5.22 % -7.27 % 0 % 4.75 %
3 Month Return 0 % 16.38 % -11.18 % -7.01 % 0 % 8.93 %
6 Month Return -45.39 % 31.62 % 10.84 % 14.76 % 6.81 % 50.7 %
9 Month Return -83.47 % -19.6 % 11.91 % 19.62 % 19.07 % -5.93 %
YTD Return 0 % 22.65 % -2.63 % 1.62 % 0 % 12.24 %
1 Year Return -83.16 % -24.06 % 16.28 % 11.31 % 14.37 % -16.01 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BWV NVO VRTX REGN SGEN MRNA
Dividend Yield Percentage (TTM) - 1.43 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -242.12 % 1.54 % 13.69 % 5.88 % -3.35 % -4.41 %
Dividend Per Share (TTM) - 1.81 % - - - -
Payout Ratio (TTM) - 37.96 % - - - -
Growth
BWV NVO VRTX REGN SGEN MRNA
Asset Growth 752.93 % 30.35 % 25.23 % 13.23 % -1.21 % -28.74 %
Gross Profit Growth - 32.32 % 9.25 % 6.49 % 22.93 % -85.12 %
Revenue Growth - 31.26 % 10.17 % 7.76 % 24.65 % -64.94 %
Revenue 3 Year - 90.51 % 59.87 % 56.27 % 91.84 % 2354.12 %
Revenue 5 Year - 124.2 % 218.58 % 97.36 % 215.48 % 1070.62 %
Revenue 10 Year - 66.11 % 608.27 % 509.63 % 494.04 % 6447.35 %
EBIT Growth -294.5 % 37.11 % -12.94 % -14.6 % 10.13 % -145 %
Net Income Growth -288.91 % 50.71 % 8.96 % -8.87 % 9.51 % -156.37 %
Net Income 3 Yeari Growth Per Share -1467.04 % 106.79 % 34.59 % 13.92 % -764.83 % -529.35 %
Net Income 5 Yeari Growth Per Share -1467.04 % 133.86 % 70.33 % 63.31 % -276.93 % -160.17 %
Net Income 10 Yeari Growth Per Share -1467.04 % 98.61 % 809.6 % 811.34 % -624.16 % -2046.03 %
Operating Income Growth -294.5 % 37.11 % -12.94 % -14.6 % 10.13 % -145 %
Operating Cash Flow Growth (CFG) -325.53 % 38.06 % -14.35 % -8.39 % 9.07 % -162.6 %
Operating 3 Year CFG -849.19 % 118.29 % 9.63 % 77.63 % -148.34 % -253.42 %
Operating 5 Year CFG -849.19 % 163.51 % 174.78 % 111.31 % -195.86 % -100.11 %
Operating 10 Year CFG -849.19 % 150.92 % 5187.08 % 663.48 % -2622.09 % -4698.89 %
EPS Growth -248.39 % 52.28 % 8.33 % -8.54 % 10.81 % -158.04 %
EPS Diluted Growth -248.39 % 52.37 % 8.35 % -9.03 % 10.81 % -161.33 %
Book Value Per Share 1276.43 % 29 % 25.58 % 14.4 % -9.83 % -21.18 %
Share Holder 3 Year Equity Growth Per Share 236.04 % 75.22 % 104.06 % 138.48 % 33.92 % 439.47 %
Share Holder 5 Year Equity Growth Per Share 236.04 % 121.9 % 291.14 % 199.46 % 220.81 % 92.24 %
Share Holder 10 Year Equity Growth Per Share 236.04 % 49.62 % 1030.79 % 1201.51 % 691.19 % 1519.81 %
Dividend Per Share Growth - 26.89 % - - - 59.65 %
Dividend 3 Year Growth Per Share - 64.4 % -100 % - - 3725.19 %
Dividend 5 Year Growth Per Share - 80.03 % -100 % - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth - 4.74 % 44.1 % 0.06 % -23.28 % 3.58 %
Free Cash Flow Growth -325.59 % 9.17 % -16.47 % -17.11 % 3.67 % -183.5 %
Updated On 31 Dec 2022 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
BWV NVO VRTX REGN SGEN MRNA
Gross Profit Margin TTM - 84.6 % 87.21 % 87.87 % 75.4 % 31.49 %
Return on Assets TTM -65.34 % 26.61 % 15.92 % 11.95 % -20.64 % -25.58 %
Return on Equity TTM -111.44 % 90.49 % 22.62 % 16.07 % -28.06 % -29.87 %
Return on Capital Employed TTM -168.34 % 70.82 % 19.82 % 13.65 % -29.5 % -27.51 %
Net Income Per EBT TTM 99.68 % 79.95 % 82.64 % 94.15 % 101.53 % 119.58 %
EBT Per Ebit TTM 106.06 % 102.05 % 115.19 % 103.76 % 93.47 % 92.99 %
EBIT Per Revenue TTM - 44.16 % 38.53 % 30.85 % -34.37 % -61.88 %
Cash Flow To Debt Ratio TTM -93.42 % 403.27 % 437.57 % 169.97 % -475.96 % -250.84 %
Receivables Turnover TTM - 3.09 6.31 2.31 3.64 6.34
Payables Turnover TTM - 1.4 3.46 2.62 2.52 9.03
Inventory Turnover TTM - 1.12 1.71 0.62 1.07 23.23
Fixed Asset Turnover TTM - 255.34 % 679.28 % 316.35 % 471.71 % 257.71 %
Asset Turnover TTM - 73.85 % 43.42 % 39.65 % 63.3 % 37.18 %
Operating Cash Flow Per Share TTM -0.69 24.39 13.73 43.1 -2.87 -8.18
Free Cash Flow Per Share TTM -0.69 15.68 12.72 35.77 -3.73 -10.04
Cash Per Share TTM 43.68 % 677.09 % 4354.48 % 10173.36 % 657.5 % 2258.27 %
Operating Cash Flow Sales Ratio TTM - 46.89 % 35.84 % 35.02 % -23.48 % -45.52 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.41 % 64.29 % 92.69 % 83.01 % 129.82 % 122.67 %
Cash Flow Coverage Ratios TTM -93.42 % 403.27 % 437.57 % 169.97 % -475.96 % -250.84 %
Price To Free Cash Flows Ratio TTM -0.28 55.43 31.21 25.26 -61.54 -11.17
Price To Operating Cash Flows Ratio TTM -0.26 36.17 28.86 20.71 -79.67 -13.64
Price Cash Flow Ratio TTM -0.26 36.17 28.86 20.71 -79.67 -13.64
Income Statement (TTM)
BWV NVO VRTX REGN SGEN MRNA
Revenue $0B $232.26B $9.84B $13.12B $1.96B $6.75B
Gross Profit $0B $196.5B $8.58B $11.3B $1.55B $2.06B
Gross Profit Ratio 0% 84.6% 87.17% 86.16% 79.1% 30.52%
EBITDA $-0.01B $112.94B $3.93B $5.13B $-0.62B $-3.21B
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-4.71B
EPS Diluted -1.08 18.62 13.89 34.77 -3.3 -12.34
Balance Sheet (MRQ)
BWV NVO VRTX REGN SGEN MRNA
Long Term Debt $0B $20.53B $0.72B $2.7B $0.04B $1.22B
Total Liabilities $0B $207.93B $5.15B $7.11B $0.87B $4.57B
Total Equity $0.02B $106.56B $17.58B $25.97B $2.8B $13.85B
Total Investments $0B $17.5B $3.45B $13.51B $1.42B $4.68B
Total Debt $0B $27.01B $0.81B $2.7B $0.04B $1.24B
Total Assets $0.03B $314.49B $22.73B $33.08B $3.67B $18.43B
Cash Flow Statement (TTM)
BWV NVO VRTX REGN SGEN MRNA
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-4.71B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $0.75B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $108.91B $3.54B $4.59B $-0.45B $-3.12B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.71B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.86
ABCL AbCellera Biologics Inc. 3.84
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 3.44
ABIO ARCA biopharma, Inc. 3.43
ABOS Acumen Pharmaceuticals, Inc. 3.18
ABSI Absci Corporation 4.78
ABUS Arbutus Biopharma Corporation 2.78
ABVC ABVC BioPharma, Inc. 1.4
ABVX Abivax SA American Depositary Shares 15.52
ACAD ACADIA Pharmaceuticals Inc. 17.1
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.59
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.76
ACHV Achieve Life Sciences, Inc. 4.57
ACIU AC Immune SA 2.4
ACLX Arcellx, Inc. 51.11
ACRV Acrivon Therapeutics, Inc. Common Stock 10
ACST Acasti Pharma Inc. 2.68
ETFs With Exposure to BWV
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 252.77
VXF Vanguard Extended Market Index Fund 0 167.37
IWC iShares Micro-Cap ETF 0 113.5
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 126.95
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 126.96
VEMPX Vanguard Extended Market Index InstlPlus 0 313.29
Unlock